SeaStar Medical Holding (ICU) Interest & Investment Income (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly Interest & Investment Income came in at $91000.0 in Q1 2026, up 89.58% YoY from $48000.0 in Q1 2025, and down 27.2% on a QoQ basis from $125000.0 in Q4 2025.
SeaStar Medical Holding (ICU) Interest & Investment Income (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 5 years of Interest & Investment Income data on file, last reported at $91000.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 89.58% year-over-year to $91000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $368000.0 (up 145.33% YoY) and the FY2025 annual result came in at $325000.0, up 221.78% from the prior year.
- Interest & Investment Income retreated to $91000.0 in Q1 2026, from $125000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $361717.0 in Q3 2022 to a low of $2604.0 in Q1 2022.
- A 4-year average of $86357.3 and a median of $58000.0 in 2024 frame the typical range for Interest & Investment Income.
- The widest YoY moves for Interest & Investment Income: up 13493.27% in 2022, down 48.46% in 2022.
- Tracing ICU's Interest & Investment Income over 4 years: stood at $361717.0 in 2022, then sank by 94.75% to $19000.0 in 2024, then surged by 557.89% to $125000.0 in 2025, then retreated by 27.2% to $91000.0 in 2026.
- The last three Interest & Investment Income figures came in at $91000.0 (Q1 2026), $125000.0 (Q4 2025), and $107000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69,000.00 |
| Mar 31, 2026 | 91,000.00 |
| Dec 31, 2025 | 125,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Mar 31, 2025 | 48,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Sep 30, 2022 | 361,717.00 |
| Jun 30, 2022 | 67,609.00 |
| Mar 31, 2022 | 2,604.00 |
| Dec 31, 2021 | 7,405.00 |
| Sep 30, 2021 | 2,661.00 |
| Mar 31, 2021 | 1,754.00 |